Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial-Reference-Cited by-同舟云学术

Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial

Published:2021-02-26 Issue:6 Volume:23 Page:1409-1414
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ahmad Ehtasham¹²^ORCID,Waller Helen L.¹²,Sargeant Jack A.¹²^ORCID,Webb M'Balu A.¹²,Htike Zin Zin¹³,McCann Gerry P.²⁴,Gulsin Gaurav²⁴,Khunti Kamlesh¹⁵^ORCID,Yates Tom¹²,Henson Joseph¹²,Davies Melanie J.¹²^ORCID,Webb David R.¹²^ORCID

Affiliation:

1. Diabetes Research Centre University of Leicester Leicester UK

2. NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust and the University of Leicester Leicester UK

3. Nottingham University Hospitals Nottingham UK

4. Department of Cardiovascular Sciences University of Leicester Leicester UK

5. NIHR Applied Research Collaborations (ARC) East Midlands Leicester UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14343